Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID ZONGSHENG CHANG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1982718078
CMS profile
226014
Location
NEWPORT NEWS, VA

General Payments · PY2018–2024

$76,649.30

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$27,448.08

23 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $21,116.71 15
Takeda Pharmaceuticals U.S.A., Inc. $2,760.00 1
Bayer HealthCare Pharmaceuticals Inc. $1,710.00 1
TAIHO ONCOLOGY, INC. $1,560.00 1
BeiGene USA, Inc. $133.50 1
CHIESI USA, INC. $83.76 1
Ipsen Biopharmaceuticals, Inc $66.23 2
ABBVIE INC. $17.88 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $178.46 7
PY2019 $309.70 5
PY2020 $3,353.96 5
PY2021 $6,770.91 9
PY2022 $4,172.94 8
PY2023 $34,415.25 29
PY2024 $27,448.08 23

Payment records · PY2024 (23)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.88 08/24/2024 Food and Beverage Undisputed 01/23/2026 1103440902 CMS
AstraZeneca Pharmaceuticals LP $40.20 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1104302190 CMS
AstraZeneca Pharmaceuticals LP $116.05 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105840531 CMS
AstraZeneca Pharmaceuticals LP $4,100.00 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105691873 CMS
AstraZeneca Pharmaceuticals LP $120.01 04/12/2024 Food and Beverage Undisputed 01/23/2026 1104578358 CMS
AstraZeneca Pharmaceuticals LP $43.55 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1105693183 CMS
AstraZeneca Pharmaceuticals LP $4,100.00 04/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104443874 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 07/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105681051 CMS
AstraZeneca Pharmaceuticals LP $210.13 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1104645079 CMS
AstraZeneca Pharmaceuticals LP $121.83 09/07/2024 Food and Beverage Undisputed 01/23/2026 1104783354 CMS
AstraZeneca Pharmaceuticals LP $525.52 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1105792180 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 09/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105758343 CMS
AstraZeneca Pharmaceuticals LP $300.00 10/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105700132 CMS
AstraZeneca Pharmaceuticals LP $119.32 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104465166 CMS
AstraZeneca Pharmaceuticals LP $300.00 12/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105802761 CMS
AstraZeneca Pharmaceuticals LP $20.10 12/18/2024 Travel and Lodging Undisputed 01/23/2026 1105753203 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,710.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1086238596 CMS
BeiGene USA, Inc. $133.50 08/23/2024 Food and Beverage Undisputed 01/23/2026 1120857891 CMS
Chiesi USA, Inc. $83.76 05/09/2024 Food and Beverage Undisputed 01/23/2026 1151803083 CMS
Ipsen Biopharmaceuticals, Inc $16.23 06/11/2024 Education Undisputed 01/23/2026 1091966106 CMS
Ipsen Biopharmaceuticals, Inc $50.00 10/06/2024 Food and Beverage Undisputed 01/23/2026 1091966108 CMS
TAIHO ONCOLOGY, INC. $1,560.00 11/14/2024 Consulting Fee Undisputed 01/23/2026 1137936987 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,760.00 05/23/2024 Consulting Fee Undisputed 01/23/2026 1144955061 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.